Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ginkgo biloba extract improves cognitive performance in Alzheimer's, dementia -- study.

This article was originally published in The Tan Sheet

Executive Summary

GINKGO BILOBA EXTRACT IMPROVES MENTAL PERFORMANCE IN DEMENTIAS for individuals with Alzheimer's disease and multi-infarct dementia, researchers report in a double-blind, placebo-controlled study of 327 patients published in the Oct. 22 Journal of the American Medical Association. Based on the results of the 52-week trial, ginkgo biloba leaf extract (EGb 761) "appears to stabilize and, in an additional 20% of cases (vs. placebo), improve patient's functioning for periods of six months to a year," Pierre Le Bars, MD/PhD, New York Institute for Medical Research, et al., state.
Advertisement

Related Content

NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers
NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers
NCCAM Awards Funds For Ginkgo Biloba Trial, Five Research Centers

Topics

Advertisement
UsernamePublicRestriction

Register

PS087697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel